Vildagliptin is a once-daily dipeptidyl peptidase 4 (DPP-4) inhibitor used in the management of type 2 diabetes mellitus. Vildagliptin (LAF237) is an orally active antihyperglycemic agent that selectively inhibits the dipeptidyl peptidase-4 (DPP-4) enzyme. Vildagliptin is an oral medication for type 2 diabetes that targets the incretin system, a network of hormones that regulate blood sugar. Learn how it works, how to use it, what side effects and precautions to consider, and how it compares to other DPP-4 inhibitors. Learn about Vildagliptin 50 mg, its uses, dosage, side effects, and safety tips for type 2 diabetes. Helps manage blood sugar with minimal risk of side effects. Vildagliptin is an oral antidiabetic agent for type 2 diabetes mellitus. Learn about its indications, contraindications, side effects, precautions, and brands available in India and internationally.
